REG - Induction Healthcare - AIM Rule 17 Schedule 2(g) Update

Induction HealthcareAnnouncement

30/03/2022 11:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220330:nRSd5935Ga&default-theme=true

RNS Number : 5935G  Induction Healthcare Group PLC   30 March 2022

30 March 2022

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

AIM Rule 17 Schedule 2(g) Update

 

Induction (AIM: INHC), a leading virtual care platform driving digital
transformation of healthcare systems worldwide, announces the following
information relating to directors' disclosure under Schedule Two, paragraph
(g) of the AIM Rules for Companies:

 

Chris Spencer, non-executive Chairman, has been a director of a private
company, Acea Health Limited, since 2 April 2018.  On 29 March 2022, Acea
Health Limited entered into creditors voluntary liquidation.

 

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

 James Balmain, Chief Executive Officer

 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0)20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Paul McManus / Stephanie Cuthbert                      Mob: +44(0)7980 541 893 / +44 (0)7796 794 663

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - enabling a more flexible,
efficient and positive experience for the communities they serve. Purpose
built for integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even greater when
integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBKKBQCBKKCNN